LEV Bridge & Synergistic Interventions for AI-Enhanced Life Extension

Abstract This paper explores the groundbreaking potential of combining AI-controlled steroid delivery ("LEV Bridge") with synergistic interventions and advanced cybernetics to achieve radical life extension in humans. The "LEV Bridge" concept proposes the strategic, time-limited use of anabolic steroids, precisely managed by artificial intelligence, to preserve and enhance muscle mass and bone density in aging individuals. This approach acts as a bridge to future rejuvenation therapies while mitigating age-related decline. By integrating "LEV Bridge" with regenerative medicine, senolytics, CRISPR-based gene editing, and bio-neural.ai's intelliSync cybernetic systems, powered by the advanced Neural-Matrix Synaptic Resonance Networks (NM-SRNs) AI, we can potentially achieve unprecedented increases in human lifespan and healthspan. This paper delves into the scientific rationale, technological advancements, and potential benefits of this integrated approach, while addressing ethical considerations and outlining a positive vision for the future of AI-enhanced life extension.